3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
29
Colonic Neoplasms
13
Colorectal Neoplasms
12
Rectal Neoplasms
10
Prostatic Neoplasms
9
Neoplasms
8
Endometrial Neoplasms
7
Uterine Cervical Neoplasms
6
Lung Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Overweight
5
Obesity
5
Motor Activity
5
Anxiety Disorders
5
Sexuality
4
Sexual Dysfunction, Physiological
4
Ovarian Neoplasms
4
Depression
4
Breast Carcinoma In Situ
4
Unspecified Adult Solid Tumor, Protocol Specific
3
Small Cell Lung Carcinoma
3
Pancreatic Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Carcinoma, Intraductal, Noninfiltrating
3
Behavior
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Urinary Bladder Neoplasms
2
Tobacco Use Disorder
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Interventions
Radiosurgery
24
lenvatinib
19
Radiofrequency Ablation
16
Hepatectomy
13
Sorafenib
12
Surgical Procedures, Operative
9
Radiotherapy
9
camrelizumab
7
Magnetic Resonance Spectroscopy
7
Blood Specimen Collection
7
Bevacizumab
7
sintilimab
6
apatinib
6
Immune Checkpoint Inhibitors
6
Electroporation
6
atezolizumab
5
tislelizumab
4
Yttrium-90
4
Proton Therapy
4
Oxaliplatin
4
Liver Transplantation
4
Doxorubicin
4
Control Groups
4
Cisplatin
4
Chemoembolization, Therapeutic
4
Catheter Ablation
4
spartalizumab
3
entecavir
3
X-Rays
3
Standard of Care
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Carcinoma, Hepatocellular
×
Counseling
×
Clear all
NCT03185416
2018-04-09
EPIICC
University of Miami
Phase NA
Withdrawn